Convergence Investment Partners’s Cardiovascular Systems, Inc. CSII Stock Holding History

Convergence Investment Partners’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-5,869	Closed	-$252K	–	372
2019 Q2	$252K	Sell	5,869 -2,378	-29%	-$92.3K	0.06%	216
2019 Q1	$319K	Buy	+8,247	New	+$280K	0.07%	214
2017 Q3	–	Sell	-40,480	Closed	-$1.3M	–	412
2017 Q2	$1.3M	Sell	40,480 -15,823	-28%	-$482K	0.19%	206
2017 Q1	$1.59M	Sell	56,303 -7,107	-11%	-$189K	0.22%	173
2016 Q4	$1.53M	Buy	+63,410	New	+$1.56M	0.21%	194

Other funds holding CSII

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Convergence Investment Partners's CSII Position: Q3 2019 in Review

Convergence Investment Partners sold out of Cardiovascular Systems, Inc. (CSII) in Q3 2019, closing a stake of 5,869 shares — an estimated $252K sold.

Convergence Investment Partners first reported a position in CSII in Q4 2016 and held it in 5 quarters. The position peaked at $1.59M in Q1 2017. 190 funds tracked by Wall St. Rank hold CSII as of Q3 2019.

Convergence Investment Partners reported no remaining Cardiovascular Systems, Inc. position as of Q3 2019 after selling out during the quarter.
Convergence Investment Partners sold 5,869 Cardiovascular Systems, Inc. shares in Q3 2019, an estimated $252K.
Convergence Investment Partners first reported a position in Cardiovascular Systems, Inc. in Q4 2016 and held it in 5 quarters.
Convergence Investment Partners's Cardiovascular Systems, Inc. position peaked at $1.59M in Q1 2017.
190 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q3 2019.

Based on Convergence Investment Partners's 13F filing for Q3 2019, filed 22 Oct 2019.